These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 24467214
1. Nitrofurantoin enteric pellets with high bioavailability based on aciform crystalline formation by wet milling. Yu H, Pan L, Li P, Zhang K, Lin X, Zhang Y, Tang X. Pharm Dev Technol; 2015 Jun; 20(4):433-41. PubMed ID: 24467214 [Abstract] [Full Text] [Related]
2. Dry state microcrystals stabilized by an HPMC film to improve the bioavailability of andrographolide. Zhang Y, Hu X, Liu X, Dandan Y, Di D, Yin T, Zhang S, Tang X. Int J Pharm; 2015 Sep 30; 493(1-2):214-23. PubMed ID: 26216414 [Abstract] [Full Text] [Related]
3. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods. Meng J, Li S, Yao Q, Zhang L, Weng Y, Cai C, Xu H, Tang X. Drug Dev Ind Pharm; 2014 Jul 30; 40(7):929-36. PubMed ID: 23614872 [Abstract] [Full Text] [Related]
4. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C. Eur J Pharm Biopharm; 2008 Sep 30; 70(1):302-12. PubMed ID: 18579353 [Abstract] [Full Text] [Related]
5. Effect of the granulation process on nitrofurantoin granule characteristics. Arnaud P, Brossard D, Chaumeil JC. Drug Dev Ind Pharm; 1998 Jan 30; 24(1):57-66. PubMed ID: 15605598 [Abstract] [Full Text] [Related]
6. Improved dissolution rate and bioavailability of fenofibrate pellets prepared by wet-milled-drug layering. Wang P, Luo Q, Miao Y, Ying L, He H, Cai C, Tang X. Drug Dev Ind Pharm; 2012 Nov 30; 38(11):1344-53. PubMed ID: 22283480 [Abstract] [Full Text] [Related]
7. Formulation strategy of nitrofurantoin: co-crystal or solid dispersion? Teoh XY, Bt Mahyuddin FN, Ahmad W, Chan SY. Pharm Dev Technol; 2020 Feb 30; 25(2):245-251. PubMed ID: 31690150 [Abstract] [Full Text] [Related]
8. Preparation and in vitro-in vivo evaluation of double layer coated and matrix sustained release pellet formulations of diclofenac potassium. Fu J, Wang X, Xu L, Meng J, Weng Y, Li G, He H, Tang X. Int J Pharm; 2011 Mar 15; 406(1-2):84-90. PubMed ID: 21219996 [Abstract] [Full Text] [Related]
11. Mechanistic Insight of Polymer Effects on the Kinetic of Solution-Mediated Phase Transformation of Nitrofurantoin Anhydrate to Monohydrate. Wang X, Ji X, Cai T, Guo M. Pharm Res; 2023 Jun 15; 40(6):1587-1598. PubMed ID: 37059941 [Abstract] [Full Text] [Related]
13. A novel gastro-floating multiparticulate system for dipyridamole (DIP) based on a porous and low-density matrix core: in vitro and in vivo evaluation. Li Z, Xu H, Li S, Li Q, Zhang W, Ye T, Yang X, Pan W. Int J Pharm; 2014 Jan 30; 461(1-2):540-8. PubMed ID: 24368104 [Abstract] [Full Text] [Related]
14. Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability. Yang H, Teng F, Wang P, Tian B, Lin X, Hu X, Zhang L, Zhang K, Zhang Y, Tang X. Int J Pharm; 2014 Dec 30; 477(1-2):88-95. PubMed ID: 25455766 [Abstract] [Full Text] [Related]
15. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A, Remon JP, Foreman P, Vervaet C. Eur J Pharm Biopharm; 2007 Nov 30; 67(3):715-24. PubMed ID: 17537625 [Abstract] [Full Text] [Related]
16. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions. Kumar S, Burgess DJ. Int J Pharm; 2014 May 15; 466(1-2):223-32. PubMed ID: 24614581 [Abstract] [Full Text] [Related]
17. Effect of environmental humidity on the transformation pathway of nitrofurantoin modifications during grinding and the physicochemical properties of ground products. Otsuka M, Matsuda Y. J Pharm Pharmacol; 1993 May 15; 45(5):406-13. PubMed ID: 8099957 [Abstract] [Full Text] [Related]
18. Preparation and in vitro-in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability. Xu L, Luo Y, Feng J, Xu M, Tao X, He H, Tang X. Int J Pharm; 2012 Jan 17; 422(1-2):9-16. PubMed ID: 22001837 [Abstract] [Full Text] [Related]